SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,580.54 -1,247.71
( -1.67%)

Global Indices

Nasdaq

51,527.73 -356.96
(-0.69%)

Dow Jones

7,726.85 -58.79
(-0.76%)

Hang Seng

65,657.92 638.97
(0.98%)

Nikkei 225

10,680.49 -24.77
(-0.23%)

Forex

USD-INR

95.65 -0.17
(-0.17%)

EUR-INR

109.56 -0.37
(-0.34%)

GBP-INR

127.74 -0.44
(-0.34%)

JPY-INR

0.61 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ambuja Cements Ltd

Industry : Cement - North India

BSE Code

ISIN Demat

Book Value()

500425

INE079A01024

211.5270843

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMBUJACEM

25.96

97529.07

EPS(TTM)

Face Value()

Div & Yield %

15.12

0.51

Back

poonawalla fincorp limited

Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter

Aug 03,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 15.69% to Rs 237.18 crore in the quarter ended June 2026 as against Rs 205.01 crore during the previous quarter ended June 2025. Sales rose 16.55% to Rs 938.44 crore in the quarter ended June 2026 as against Rs 805.17 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	938.44	805.17	17
OPM %	31.49	31.20	-
PBDT	338.29	294.50	15
PBT	322.45	278.98	16
NP	237.18	205.01	16

73,580.54 -1,247.71 ( -1.67%)

51,527.73 -356.96 (-0.69%)

7,726.85 -58.79 (-0.76%)

65,657.92 638.97 (0.98%)

10,680.49 -24.77 (-0.23%)

95.65 -0.17 (-0.17%)

109.56 -0.37 (-0.34%)

127.74 -0.44 (-0.34%)

0.61 0.00 (-0.29%)